4.7 Article

The PI3K p110α isoform regulates endothelial adherens junctions via Pyk2 and Rac1

期刊

JOURNAL OF CELL BIOLOGY
卷 188, 期 6, 页码 863-876

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200907135

关键词

-

资金

  1. Association for International Cancer Research
  2. Cancer Research UK
  3. Biotechnology and Biological Sciences Research Council
  4. European Commission Framework 6 [LSHG-CT-2003-502935]
  5. Bettencourt-Schueller Foundation
  6. Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: researchfish

向作者/读者索取更多资源

Endothelial cell-cell junctions control efflux of small molecules and leukocyte transendothelial migration (TEM) between blood and tissues. Inhibitors of phosphoinositide 3-kinases (PI3Ks) increase endothelial barrier function, but the roles of different PI3K isoforms have not been addressed. In this study, we determine the contribution of each of the four class I PI3K isoforms (p110 alpha, -beta, -gamma, and -delta) to endothelial permeability and eukocyte TEM. We find that depletion of p110 alpha but not other p110 isoforms decreases TNF-induced endothelial permeability, Tyr phosphorylation of the adherens junction protein vascular endothelial cadherin (VE-cadherin), and leukocyte TEM. p110 alpha selectively mediates activation of the Tyr kinase Pyk2 and GTPase Rac1 to regulate barrier function. Additionally, p110 alpha mediates the association of VE-cadherin with Pyk2, the Rac guanine nucleotide exchange factor Tiam-1 and the p85 regulatory subunit of PI3K. We propose that p110 alpha regulates endothelial barrier function by inducing the formation of a VE-cadherin-associated protein complex that coordinates changes to adherens junctions with the actin cytoskeleton.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据